Bird & Bird ATMD advises iX Biopharma on rights issue

Contacts

marcus chow module
Marcus Chow

Partner
Singapore

We understand clients' needs, local markets, different business cultures.

jolie giouw module
Jolie Giouw

Counsel
Singapore

I am a Counsel in our Corporate and Commercial Group in Singapore. I am involved in a wide range of corporate matters across various sectors, with a focus on corporate finance as well as mergers and acquisitions.

xingyi tan module
Xing Yi Tan

Associate
Singapore

I am an associate in Bird & Bird ATMD's Corporate & Commercial Group, based in Singapore. My key areas of practice include equity capital markets and mergers and acquisitions.

Bird & Bird ATMD is pleased to advise iX Biopharma, a Singapore Exchange (SGX) listed pharmaceutical company, on its renounceable non-underwritten rights issue.

Under the rights issue, each eligible shareholder can subscribe for 11 rights shares at an issue price of S$0.03 per share for every 50 existing shares held in iX Biopharma as at record date 26 June 2024. Additionally, for every two rights shares subscribed, one free warrant will be issued, allowing the holder to purchase one new share in the company at S$0.06.

iX Biopharma is undertaking the rights cum warrants issue to raise funds to, amongst others, advance the development of iXB 401 sublingual semaglutide wafers as a treatment for Type 2 diabetes and obesity, as well as to fund the sales and marketing activities of its innovative supplements including NAD+ sublingual wafers. 

Bird & Bird’s team was led by Corporate Partner Marcus Chow and supported by Counsel Jolie Giouw and Associate Tan Xing Yi.

News & Deals

More News & Deals

News

Bird & Bird recognised in Global Arbitration Review’s "GAR 100" list

Apr 25 2025

Read More

Deal

Bird & Bird advises the L'Oréal Group on its exclusive beauty partnership with JACQUEMUS, as well as on its minority stake acquisition

Apr 24 2025

Read More

News

Bird & Bird participates in JuriAI Ring to establish world’s first AI benchmarking index for legal sector

Apr 23 2025

Read More

News

Bird & Bird strengthens leadership in Finland office to support growth ambitions

Apr 22 2025

Read More

News

First hearing for PI damages per RoP 213.2 at the UPC - another “first” for Bird & Bird and its clients NanoString/Bruker

Apr 22 2025

Read More

News

Bird & Bird China wins CBLJ "Deals of the Year 2024"

Apr 17 2025

Read More